"Endless Ark" has completed a seed round of financing worth tens of millions.

36Kr learned that "Endless Ark", an AI-driven biotech pharmaceutical company, announced the completion of a multi-million yuan seed round of financing, led by Monolith Capital. Endless Ark Technology was founded by ZHAO Simiao, a doctoral student at the University of Oxford. It is committed to developing longevity drugs through cross-species AI models and exploring therapies that can improve organ function.